American Thyroid Association Spring Symposium and Research Summit 2013
Treatment of Hypothyroidism: Exploring the Possibilities
Levothyroxine has been considered the standard of care for treatment of hypothyroidism for many years. This treatment is easy to administer, efficacious, has a long serum half-life, and results in resolution of the sign and symptoms of hypothyroidism in the majority of patients. However, a proportion of patients being treated for hypothyroidism do not feel that they have been returned to optimum health by their therapy. The purpose of this meeting is to re-examine the evidence concerning alternatives therapies other than levothyroxine, to discuss gaps in our current knowledge of these therapies, and to determine whether new data provides reason to pursue these therapies. Read More…
WHY SHOULD YOU ATTEND?
The American Thyroid Association is the leading organization focused on thyroid biology and the prevention and treatment of thyroid disorders through excellence and innovation in research, clinical care, education, and public health. Earn CME credits, hear innovative talks, participate in interactive sessions, develop professionally with state of the art information, and meet with friends and colleagues.
WHO WILL BE THERE?
The community of endocrinologists, internists, surgeons, basic scientists, nuclear medicine scientists, pathologists, endocrine fellows and nurses, physician assistants and other health care professionals who wish to broaden and update their knowledge of the thyroid gland and its disorders. One page meeting flyer (PDF File, 486 KB)
JOIN THE ATA!
ATA members enjoy regular discounts on meeting registration, access to over 1400 endocrinologists, surgeons and health professional colleagues interested in thyroid disorders and related conditions, the opportunity to earn CME credits, and information on late-breaking research and peer generated thyroid guidelines. To become a member of the ATA, click here to learn how to join and become a part of the collegial thyroid world!
